Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Palantir emphasizes software-driven AI workflows with an asset-light model, while Oracle bets on cloud-scale GPU depl...
Bitcoin miners face mounting strain as key metrics show bitcoin miners under pressure amid softer prices, signaling s...
Two giant asset managers closed a record private credit financing to accelerate Anthropic's compute. Here’s what that...
Solana is rapidly gaining ground in decentralized finance thanks to speed and low costs. This article explores a prac...
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...
Joby Aviation just crossed a major regulatory milestone, but what does that mean for investors? This in-depth guide b...
A groundbreaking collaboration could redefine how AI and space tech work together. This article examines what spacex'...
In a striking move, trump’s crypto disclosure exposes how policy signals and private crypto stakes collide at the hig...
BNB Chain completes 36th quarterly burn, marking the third burn of 2026. The auto-burn removed 1.615 million BNB, bri...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
An anonymous trader using a quiet on-chain footprint has amassed about $7 million in unrealized profits by betting ag...